1. What is the size of the Europe pharmaceutical packaging market in 2025?
The Europe pharmaceutical packaging market was valued at USD 34.00 billion in 2025 and is projected to reach USD 62.34 billion by 2035, growing at a CAGR of 6.25%.
+1 2315155523
Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Research Analyst


The Europe pharmaceutical packaging market is undergoing a structural transformation driven by regulatory tightening, demographic shifts, and a fundamental pivot toward sustainability. Our proprietary primary research estimates the market at USD 34.00 billion in 2025, with a clear trajectory to USD 62.34 billion by 2035, reflecting a CAGR of 6.25% over the forecast period. This expansion is underpinned by an aging population, rising chronic disease prevalence, and the rapid commercialization of biologics and injectable therapies.
The region remains the second-largest global market for pharmaceutical packaging, accounting for approximately 25.3% of worldwide revenue in 2024. Germany stands as the largest country market, commanding a 21.8% share of the European total, followed by France, the UK, Italy, and Switzerland, which collectively host a dense ecosystem of pharmaceutical manufacturing, contract development and manufacturing organizations (CDMOs), and packaging converters.
Key market metrics (2025 baseline):
| Metric | Value |
|---|---|
| Market size (2025) | USD 34.00 billion |
| Forecast (2035) | USD 62.34 billion |
| CAGR (2026-2035) | 6.25% |
| Largest material segment | Plastics (~45% share) |
| Largest packaging type | Bottles & Jars (~40% share) |
| Largest dosage form | Oral solids (~50% share) |
| Largest end user | Retail pharmacies (~55% share) |
| Largest distribution channel | Distributors & wholesalers (~50% share) |
The European pharmaceutical packaging value chain is highly integrated, spanning raw material suppliers to end-user pharmacies.
Europe is a net exporter of pharmaceutical packaging, with Germany, Italy, and Switzerland serving as key manufacturing and export hubs. Intra-European trade is substantial, driven by the integration of pharmaceutical supply chains across borders.
| Country | Market Share (2024) | Attractiveness Drivers |
|---|---|---|
| Germany | 21.8% | Largest pharmaceutical manufacturing base, strong R&D, high regulatory influence |
| France | 14.0% | Robust biotech sector, government support for innovation |
| United Kingdom | 13.0% | Post-Brexit regulatory autonomy, strong generics market |
| Italy | 11.0% | Cost-competitive manufacturing, growing CDMO cluster |
| Spain | 9.0% | Expanding healthcare expenditure, gateway to Latin America |
| Switzerland | 8.0% | High-value specialty pharma, premium packaging demand |
Investment opportunities are concentrated in sustainable packaging innovation, smart packaging technologies (RFID, NFC), and prefilled syringe capacity expansion. Germany and Switzerland offer the highest returns for high-barrier and smart packaging, while Italy and Spain present cost-effective manufacturing hubs for generic drug packaging.
Several underpenetrated segments offer significant growth potential:
The European pharmaceutical packaging market is moderately concentrated, with global players and regional specialists competing on innovation, sustainability, and regulatory compliance.
Leading companies include Amcor plc, Gerresheimer AG, Schott Pharma AG & Co. KGaA, AptarGroup Inc., Becton Dickinson & Co., West Pharmaceutical Services, Berry Global Group, and WestRock. These companies are actively investing in sustainable materials, capacity expansion, and digitalization.
Recent strategic developments (2024-2026):
These developments underscore the industry's pivot toward sustainability, patient-centric design, and supply chain resilience.
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.25% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Director of Packaging Procurement | 30% |
| Head of Regulatory Affairs | 25% |
| R&D Director for Drug Delivery | 20% |
| Supply Chain Manager | 15% |
| CEO/President | 10% |
| Company Type | Representation (%) |
|---|---|
| Pharmaceutical Manufacturers & CDMOs | 35% |
| Primary Packaging Converters | 25% |
| Raw Material Suppliers | 15% |
| Packaging Machinery Providers | 10% |
| Retail & Hospital Pharmacies | 15% |
The Europe pharmaceutical packaging market was valued at USD 34.00 billion in 2025 and is projected to reach USD 62.34 billion by 2035, growing at a CAGR of 6.25%.
Germany accounts for the largest share, approximately 21.8% of the European market in 2024, driven by its strong pharmaceutical manufacturing base and advanced packaging infrastructure.
Key trends include the shift toward sustainable and recyclable materials, the adoption of smart packaging with RFID and IoT for track-and-trace, and the rising demand for pre-filled syringes and auto-injectors for biologics.
Plastics dominate with approximately 45% share in 2025, due to their versatility, cost-effectiveness, and barrier properties, though multi-layer laminates are growing at a notable CAGR.
Pre-filled syringes offer dosing accuracy, reduce contamination risks, and enable self-administration, making them ideal for biologics and vaccines. The segment is expected to grow at the highest CAGR during 2026-2035.
Challenges include high compliance costs under EU GMP and FMD, environmental concerns over plastic waste, and the complexity of managing serialization and traceability across multi-country supply chains.